Consensus IBEX Limited

Equities

IBEX

BMG4690M1010

Market Closed - Nasdaq 04:00:00 2024-06-07 pm EDT 5-day change 1st Jan Change
15.58 USD -1.70% Intraday chart for IBEX Limited -0.45% -18.04%

Evolution of the average Target Price on IBEX Limited

Price target over the last 5 years

History of analyst recommendation changes

2055daee186e.6-epqpZNB60kVY-pR9ocri0-ISVLhzsyd3mdGyEJRhI.s4n67MYrMe9XI8bAA4BU2HwMdnAc9g5jMyHuLGdbBVnd1JzkwCNl314H7A~a63e43a80d566dfc5d97aa108f30b938
Baird Adjusts Price Target on IBEX to $20 From $21, Maintains Outperform Rating MT
RBC Lifts Price Target on IBEX to $19 From $18, Keeps Sector Perform Rating MT
Piper Sandler Downgrades IBEX to Neutral From Overweight, Price Target is $17 MT
Baird Adjusts Price Target on IBEX to $22 From $24, Keeps Outperform Rating MT
Piper Sandler Cuts Price Target on IBEX to $17 From $24, Keeps Overweight Rating MT
Citigroup Adjusts Price Target on IBEX to $18 From $23, Maintains Neutral Rating MT
Baird Adjusts Price Target on IBEX to $24 From $28, Maintains Outperform Rating MT
Truist Securities Adjusts IBEX Price Target to $25 From $32, Maintains Buy Rating MT
IBEX Downgraded by RBC to Sector Perform From Outperform, Price Target Cut to $18 From $27 MT
Piper Sandler Adjusts Price Target on IBEX to $24 From $32, Keeps Overweight Rating MT
Citigroup Adjusts Price Target on IBEX to $23 From $30, Keeps Neutral Rating MT
RBC Cuts Price Target on IBEX to $27 From $30, Citing 'Revenue Growth Pressures,' Decline in Peer Valuations; Outperform Rating Kept MT
Baird Adjusts IBEX Price Target to $28 From $32, Maintains Outperform Rating MT
RBC Raises Price Target on IBEX to $30 From $26, Maintains Outperform Rating MT
Piper Sandler Adjusts Price Target on IBEX to $29 From $27, Maintains Overweight Rating MT
Citigroup Raises Price Target on IBEX to $26 From $18, Maintains Neutral Rating MT
Truist Securities Adjusts IBEX Price Target to $27 From $22, Maintains Buy Rating MT
Piper Sandler Adjusts Price Target on IBEX to $27 From $20, Maintains Overweight Rating MT
RBC Raises Price Target on IBEX to $26 From $20, Cites 'Solid Results,' Maintains Outperform Rating MT
Truist Securities Adjusts Price Target on IBEX to $22 From $26, Reiterates Buy Rating MT
Citigroup Adjusts Price Target on IBEX to $18 From $20, Maintains Neutral Rating MT
RBC Cuts Price Target on IBEX to $20 From $22, Maintains Outperform Rating MT
Piper Sandler Trims Price Target on IBEX to $20 From $21, Reiterates Overweight Rating MT
Piper Sandler Adjusts IBEX's Price Target to $21 from $17, Keeps Overweight Rating MT
Piper Sandler Adjusts Price Target on IBEX to $17 From $20, Reiterates Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
15.58 USD
Average target price
18.67 USD
Spread / Average Target
+19.81%
High Price Target
20 USD
Spread / Highest target
+28.37%
Low Price Target
18 USD
Spread / Lowest Target
+15.53%

Consensus detail

Consensus revision (last 18 months)

Analysts covering IBEX Limited

Baird
Piper Sandler
RBC Capital Markets
Citigroup
Truist Securities
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
  1. Stock Market
  2. Equities
  3. IBEX Stock
  4. Consensus IBEX Limited